Patents by Inventor John J. Hsuan

John J. Hsuan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Eotaxin-specific antibodies
    Patent number: 6635251
    Abstract: A chemoattractant protein called “eotaxin” is capable of attracting eosinophils and of inducing eosinophil accumulation and/or activation in vitro and in vivo. Various types of agents that inhibit or otherwise hinder the production, release or activity of eotaxin may be used therapeutically in the treatment of asthma and other inflammatory diseases.
    Type: Grant
    Filed: April 14, 1999
    Date of Patent: October 21, 2003
    Assignee: Imperial College of Science, Technology & Medicine
    Inventors: Timothy J. Williams, Peter J. Jose, David A. Griffiths-Johnson, John J. Hsuan
  • Chemotactic cytokine
    Patent number: 6605702
    Abstract: A chemoattractant protein called “eotaxin” is capable of attracting eosinophils and of inducing eosinophil accumulation and/or activation in vitro and in vivo. Various types of agents that inhibit or otherwise hinder the production, release or activity of eotaxin may be used therapeutically in the treatment of asthma and other inflammatory diseases.
    Type: Grant
    Filed: November 18, 1998
    Date of Patent: August 12, 2003
    Assignee: Imperial College of Science Technology & Medicine
    Inventors: Timothy J. Williams, Peter J. Jose, David A. Griffiths-Johnson, John J. Hsuan
  • CHEMOTACTIC CYTOKINE
    Publication number: 20020081623
    Abstract: A chemoattractant protein called “eotaxin” is capable of attracting eosinophils and of inducing eosinophil accumulation and/or activation in vitro and in vivo.
    Type: Application
    Filed: November 18, 1998
    Publication date: June 27, 2002
    Inventors: TIMOTHY J. WILLIAMS, PETER J. JOSE, DAVID A. GRIFFITHS-JOHNSON, JOHN J. HSUAN
  • Chemotactic cytokine
    Patent number: 6031080
    Abstract: A chemoattractant protein called "eotaxin" is capable of attracting eosinophils and of inducing eosinophil accumulation and/or activation in vitro and in vivo. Various types of agents that inhibit or otherwise hinder the production, release or activity of eotaxin may be used therapeutically in the treatment of asthma and other inflammatory diseases.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: February 29, 2000
    Assignee: Ludwig Institute for Cancer Research Imperial College of Science, Technology & Medicine
    Inventors: Timothy J. Williams, Peter J. Jose, David A. Griffiths-Johnson, John J. Hsuan
  • Agents for inhibition of chemoattractant
    Patent number: 5993814
    Abstract: A chemoattractant protein called "eotaxin" is capable of attracting eosinophils and of inducing eosinophil accumulation and/or activation in vitro and in vivo. Various types of agents that inhibit or otherwise hinder the production, release or activity of eotaxin may be used therapeutically in the treatment of asthma and other inflammatory diseases.
    Type: Grant
    Filed: August 13, 1996
    Date of Patent: November 30, 1999
    Assignee: Imperial College of Science, Technology & Medicine
    Inventors: Timothy J. Williams, Peter J. Jose, David A. Griffiths-Johnson, John J. Hsuan